Argus Sees 'Strong Prospects' For Gilead Sciences By: Benzinga via Benzinga March 20, 2015 at 07:15 AM EDT Argus reaffirmed its Buy rating on Gilead Sciences, Inc. (NASDAQ: GILD) Thursday and maintained a $130 price target on "strong ... Read More >> Related Stocks: Gilead Sciences